Titre:
  • Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
Auteur:Cornely, Oliver A; Meyer, Ralf R.G.; Hammond, Sarah S.L.; Mullane, Kathleen K.M.; Ostermann, Helmut; Ullmann, Andrew; Zimmerli, Stefan; Van Iersel, Marlou M.L.P.S.; Hepler, Deborah D.A.; Waskin, Hetty; Kartsonis, Nicholas; Robertson, Michael; Maertens, Johan; Haider, Shariq; Grigg, Andrew; Geddes, Michelle; Aoun, Michel; Heinz, Werner W.J.; Raad, Issam Issam; Schanz, Urs
Informations sur la publication:Journal of antimicrobial chemotherapy, 72, 12, page (3501)
Statut de publication:Publié, 2017-12
Sujet CREF:Généralités
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0305-7453
info:doi/10.1093/jac/dkx263
info:scp/85042195886